Breaking News Headlines Today

News about Novo Nordisk

Stay current with all the latest and breaking news about Novo Nordisk, compare headlines and perspectives between news sources on stories happening today. In total, 176 stories have been published about Novo Nordisk which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Novo Nordisk News

Wegovy · Guam

Costco To Sell Ozempic and Wegovy for $499 a Month

48% Left coverage: 23 sources

Key Takeaways See the Story

Novo Nordisk · Denmark

Novo Nordisk to Buy U.S.-Based Akero for Up to $5.2 Billion for Promising Liver Drug

54% Center coverage: 13 sources

See the Story

Health · United States

Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

78% Center coverage: 9 sources

The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Mounjaro more accessible in lower-income countries, the global health groups told Reuters.See the Story

Novo Nordisk A/S (NYSE:NVO) Shares Down 1.4% - Time to Sell?

100% Center coverage: 1 sources

Novo Nordisk A/S (NYSE:NVO) Trading Down 1.4% - Here's WhyNovo Nordisk · Denmark Read Article

"We'll Be Looking Into a Wall": Residents Feel Intimidated by New Novo Nordisk Headquarters

100% Left coverage: 1 sources

Hellerup residents accuse Danica of ruining their view with a new headquarters for the Novo Nordisk Foundation and at the same time improving the view of a neighboring building owned by Danica. The mayor and Danica deny this.Novo Nordisk · Copenhagen Read Article

Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)

Coverage: 2 sources

Scholar Rock Holding Inc. (NASDAQ:SRRK) stock is falling on Monday with a session volume of 8.19 million versus the average volume of 2.08 million, as per data from Benzinga Pro. In a press release on Monday, the company stated that on Friday, October 10, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Catalent Indiana, LLC, a subsidiary of Novo Nordisk A/S (NYSE:NVO). The FDA inspected the facility in July and determined that t…Novo Nordisk · Indiana See the Story

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

REDMOND, Wash., Oct. 13, 2025 /PRNewswire/ -- SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868), a global Ph2/3 registrational study of izalontamab brengitecan (iza-bren) in previously untreated triple negative…Novo Nordisk · United States See the Story

Novo Nordisk Foundation commits up to DKK 200 million to fund new platform to strengthen global defence against future pandemics

100% Center coverage: 1 sources

COPENHAGEN, Denmark, Oct. 13, 2025 /PRNewswire/ -- The AI-powered Global Pathogen Analysis Platform aims to strengthen the pandemic preparedness globally. The platform will provide a state-of-the art, analytical toolkit for analysing genomic pathogen data and will be freely available to…Novo Nordisk · Denmark Read Article

Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

78% Center coverage: 9 sources

Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

100% Left coverage: 1 sources

Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, as the Ozempic maker continues to slash headcount to focus on lucrative areas of obesity and diabetes treatment.Novo Nordisk · Denmark Read Article

Novo Nordisk to Buy U.S.-Based Akero for Up to $5.2 Billion for Promising Liver Drug

54% Center coverage: 13 sources

Novo Nordisk · Denmark See the Story

Cork operations of Eli Lilly underpin Ozempic maker Novo Nordisk's dwindling market dominance

100% Left coverage: 1 sources

With Cork a crucial part of its global supply chain, Eli Lilly's weight loss drugs are shaking up an industry once ruled by Ozempic and Wegovy maker, Novo NordiskEli Lilly · Cork Read Article

Novo Nordisk cuts hit production line jobs at key US plant: Reuters

80% Center coverage: 5 sources

Novo Nordisk · Denmark See the Story

News about Novo Nordisk

News about Novo Nordisk

Covered Most By

Local News Publishers

Top Novo Nordisk News

Costco To Sell Ozempic and Wegovy for $499 a Month

Novo Nordisk to Buy U.S.-Based Akero for Up to $5.2 Billion for Promising Liver Drug

Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

Novo Nordisk A/S (NYSE:NVO) Shares Down 1.4% - Time to Sell?

"We'll Be Looking Into a Wall": Residents Feel Intimidated by New Novo Nordisk Headquarters

Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

Novo Nordisk Foundation commits up to DKK 200 million to fund new platform to strengthen global defence against future pandemics

Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

Novo Nordisk to Buy U.S.-Based Akero for Up to $5.2 Billion for Promising Liver Drug

Cork operations of Eli Lilly underpin Ozempic maker Novo Nordisk's dwindling market dominance

Novo Nordisk cuts hit production line jobs at key US plant: Reuters

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Novo Nordisk

Novo Nordisk A/S (NYSE:NVO) Shares Down 1.4% - Time to Sell?

"We'll Be Looking Into a Wall": Residents Feel Intimidated by New Novo Nordisk Headquarters

Why Is Scholar Rock Stock Trading Lower On Monday? - Scholar Rock Holding (NASDAQ:SRRK)

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

Novo Nordisk Foundation commits up to DKK 200 million to fund new platform to strengthen global defence against future pandemics

Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries

Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs

Novo Nordisk to Buy U.S.-Based Akero for Up to $5.2 Billion for Promising Liver Drug

Cork operations of Eli Lilly underpin Ozempic maker Novo Nordisk's dwindling market dominance

Novo Nordisk cuts hit production line jobs at key US plant: Reuters